Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a double blind, phase III randomized clinical trial in healthy Serbian adults

• Main Authors: Goran Stevanovic (Author), Aleksandar Obradovic (Author), Snezana Ristic (Author), Dragan Petrovic (Author), Branislava Milenkovic (Author), Danilo Mitrovic (Author), Svetlana Filipovic Vignjevic (Author), Katarina Ilic (Author), Vera Stoiljkovic (Author), Lidija Lavadinovic (Author), Mijomir Pelemis (Author), Svetlana Petrovic (Author), Ana Vidmanic (Author), Olga Popovic (Author), Natasa Eremic (Author), Erin Sparrow (Author), Guido Torelli (Author), Muriel Socquet (Author), Renée Holt (Author), Yordanka Ilieva-Borisova (Author), Yuxiao Tang (Author), Francesco Berlanda Scorza (Author), Jorge Flores (Author), Niraj Rathi (Author)
• Format: Book
• Published: SAGE Publishing, 2020-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

This study was a phase III, multicenter, double-blind, randomized, placebo-controlled trial to evaluate the safety and immunogenicity of a seasonal trivalent split, inactivated influenza vaccine (TIV) in healthy Serbian adults between the ages of 18 and 65 years. This egg-based vaccine was manufactu...